Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Dec. 3, 5:28 PM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #13 of 100 |
Slide #13. Akorn — Hi-Tech Pharmacal
Acquirer:
Akorn (AKRX)
Acquiree:
Hi-Tech Pharmacal
Details:
Akorn, Inc. (NASDAQ:AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) for $640 million in cash. The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player. This combination also brings critical mass and scale to Akorn's business and strengthens the Company's position with retail and institutional customers.
Akorn is a generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals. Co.'s segments include: Prescription Pharmaceuticals, which primarily consists of generic and branded prescription pharmaceuticals in a variety of dosage forms including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals, nasal sprays and otics; and Consumer Health, which primarily consists of branded and private-label over-the-counter products and animal health products dispensed by veterinary personnel.
Open the AKRX Page at The Online Investor »
|
|||||||||
Open the AKRX Page at The Online Investor (in a new window) »
 Free AKRX Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
